January 19, 2022 Comments Off on New patent for Novartis drug SCEMBLIX Posted in: Patent Added Annual Drug Patent Expirations for SCEMBLIX Scemblix is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There is one patent protecting…
The post New patent for Novartis drug SCEMBLIX appeared first on DrugPate…
January 19, 2022 Comments Off on New patent for Abbvie Inc drug RINVOQ Posted in: Patent Added Annual Drug Patent Expirations for RINVOQ Rinvoq is a drug marketed by Abbvie Inc and is included in one NDA. It is available from one supplier. There are eight patents…
The post New patent for Abbvie Inc drug RINVOQ appeared first on DrugPatentWatch -…
